Part 1 obgyn notes Sri Lanka
    NOTES for part 1
    /
    pathology
    /
    6.Neoplasia
    /
    10.TUMOR-ASSOCIATED INFLAMMATION

    10.TUMOR-ASSOCIATED INFLAMMATION

    Owner
    U
    Untitled
    Verification
    Tags

    Core concept

    Many cancers provoke persistent (chronic) inflammation at the tumor site.

    Instead of protecting the host, the inflammatory response becomes a powerful ally of tumor progression.

    Inflammation:

    • supplies growth signals
    • remodels tissue
    • alters immune balance
    • promotes invasion & metastasis
    • drives systemic effects like cachexia

    1️⃣ Why inflammation happens in cancers

    • Tumors invading tissue cause damage → the body initiates an inflammatory response.
    • As cancer persists & spreads, inflammation becomes chronic → pathological remodeling.
    • Advanced cancers → systemic inflammation → whole-body effects:
      • anemia of chronic disease
      • fatigue
      • cancer cachexia (muscle/fat wasting)

    Key logic:

    Never-ending “battlefield” drains the host and feeds tumor biology.

    2️⃣ How inflammatory cells promote tumor growth

    Main helpers = macrophages, neutrophils, mast cells, stromal fibroblasts.

    Mechanisms:

    • release of growth factors such as EGF → direct proliferative signaling
    • secretion of proteases (MMPs, cathepsins):
      • degrade ECM
      • release ECM-bound growth factors

    Result: tumor receives fuel + space to expand.

    3️⃣ Inflammation removes natural growth restraints

    Normal restraints:

    • cell-cell and cell-matrix adhesion limit replication
    • ECM acts as a physical brake

    Inflammatory proteases:

    • degrade adhesion molecules (e.g., cadherins, integrins)
    • degrade ECM scaffolding

    Effect: loss of contact inhibition → uncontrolled proliferation.

    4️⃣ Anoikis resistance

    • Anoikis = apoptosis triggered when epithelial cells detach from ECM.
    • A key anti-cancer safeguard: prevents wandering cells from colonizing elsewhere.

    Tumor-associated macrophages:

    • express integrins/adhesion ligands
    • provide survival signals → prevent anoikis
    • enable detached cells to survive during invasion/metastasis

    Mechanistic implication: survival advantage for migrating malignant cells.

    5️⃣ Inflammatory promotion of angiogenesis

    Pro-angiogenic mediators released by tumor-associated inflammatory cells:

    • VEGF
    • FGF
    • PDGF
    • TNF and IL-1 enhance VEGF expression

    Outcomes:

    • new vessels supply O₂/nutrients
    • facilitate removal of metabolic waste
    • provide routes for metastasis

    6️⃣ Inflammation enhances invasion & metastasis

    Key roles of inflammatory mediators:

    1. ECM breakdown
      • proteases remodel matrix → create migration channels
    2. Motility stimulation
      • TNF and EGF enhance cell movement
    3. Epithelial-to-Mesenchymal Transition (EMT)
      • triggered by TGF-β
      • epithelial → motile mesenchymal phenotype
      • required for metastasis

    Result: invasion beyond basement membrane + dissemination via vessels.

    7️⃣ Immune suppression driven by inflammation

    Chronic tumor inflammation shifts toward an M2-like wound-healing phenotype.

    Mechanisms:

    • TGF-β secretion suppresses cytotoxic responses
    • recruitment of T regulatory cells (Tregs)
    • suppression of CD8⁺ cytotoxic T cells
    • macrophages produce angiogenic and fibrogenic factors → tumor stroma support

    Conceptual model:

    Tumor microenvironment resembles a “wound that won’t heal.”

    8️⃣ Can targeting inflammation reduce cancer risk?

    Yes. Anti-inflammatory therapy reduces tumor-promoting inflammation.

    Evidence:

    • Aspirin and COX-2 inhibitors lower colorectal cancer risk
    • COX-2 promotes prostaglandin-mediated inflammation → angiogenesis + growth

    Therapeutic rationale:

    • block inflammatory drivers of tumor progression.

    9️⃣ Why hallmarks matter clinically

    • They guide how therapies are designed.
    • Each hallmark = a pathway that can be therapeutically inhibited.

    Inflammation impacts multiple hallmarks simultaneously:

    • sustaining proliferative signaling
    • activating invasion/metastasis
    • resisting cell death
    • inducing angiogenesis
    • evading immune destruction

    🔁 Ultra-Quick Recap Table

    Effect
    Mechanism
    ↑ Proliferation
    growth factors (EGF) + protease liberation of ECM-bound factors
    Remove Growth Suppressors
    proteases degrade adhesion/ECM brakes
    Resist Anoikis
    macrophage integrins support survival of detached cells
    Angiogenesis
    VEGF & other angiogenic mediators
    Invasion/Metastasis
    proteases remodel ECM + EMT (TGF-β) + TNF/EGF promote motility
    Immune Evasion
    TGF-β, Tregs, M2 macrophages suppress CD8⁺ cytotoxicity
    Therapeutic potential
    COX-2 inhibitors, aspirin reduce inflammatory signaling

    One-screen story to lock memory

    • Feed & Free
    • Growth signals + proteases free growth factors.

    • Cut the Brakes
    • Proteases shred adhesion → uncontrolled expansion.

    • Don’t Fall
    • Integrin signals prevent anoikis so travelers survive.

    • Build Roads
    • VEGF makes new vessels to supply the growing tumor.

    • Make Exits
    • ECM remodeling + EMT + motility signals → escape routes & spread.

    • Mute the Cops
    • TGF-β + Tregs shut down anti-tumor immunity; M2 macrophages help rebuild stroma.

    • Target the Helpers
    • Anti-inflammatories block the inflammatory support team.

    • Use the Map
    • Hallmarks provide therapeutic targets.